Cargando…
Interleukin 8 is a biomarker of telomerase inhibition in cancer cells
BACKGROUND: Telomerase activity is required for both initiation and maintenance of tumorigenesis and over 90% cancers overexpress telomerase. Therefore, telomerase targeting has emerged as a potential strategy for cancer treatment. In agreement with this, several telomerase inhibitors are being test...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038317/ https://www.ncbi.nlm.nih.gov/pubmed/29986697 http://dx.doi.org/10.1186/s12885-018-4633-x |